Celldex Therapeutics buy Citigroup Inc.
Start price
20.08.25
/
50%
€18.40
Target price
20.08.26
€41.27
Performance (%)
53.59%
Price
15.04.26
€27.85
Summary
This prediction is currently active. With a performance of 53.59% the BUY prediction by Citigroup_Inc_ is a big success. This prediction currently runs until 20.08.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | 4.385% | 4.385% |
| iShares Core DAX® | 0,44 % | 3,03 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % |
| iShares S&P 500 | 2,37 % | 2,68 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (NASDAQ:CLDX) had its price target lowered by analysts at Citigroup Inc. from $56.00 to $48.00. They now have a "buy" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€28.20
07.10.24
07.10.24
€63.74
07.10.25
07.10.25
-20.57%
08.10.25
08.10.25
